Clinical liver disease

Keyphrases

Publications

volume 23, number 1, 2024

Rebekah B DeCamillis, Aliza L Hekman, David H Priest
Screening for hepatitis C as part of an opioid stewardship quality improvement initiative: Identifying infected patients and analyzing linkage to care. Clinical liver disease 23 (1) (2024)
Gres Karim, Megha Reddy, Navim Mobin, Ilan Weisberg, Amreen M Dinani
Immunosuppression management for refractory checkpoint inhibitor-related hepatotoxicity. Clinical liver disease 23 (1) (2024)
Allison J Kwong, Joshua S Norman, Scott W Biggins
Management of ascites and volume overload in patients with cirrhosis. Clinical liver disease 23 (1) (2024)
Juan J Gonzalez, Elliot B Tapper
Muscle cramps in cirrhosis. Clinical liver disease 23 (1) (2024)
Juan J Gonzalez, Elliot B Tapper
Muscle cramps in cirrhosis. Clinical liver disease 23 (1) (2024)
Georgia Sofia Karachaliou, Ayako Suzuki
Metabolic dysfunction-associated steatotic liver disease: Emerging risk factors for adverse pregnancy outcomes. Clinical liver disease 23 (1) (2024)
Rebekah B DeCamillis, Aliza L Hekman, David H Priest
Screening for hepatitis C as part of an opioid stewardship quality improvement initiative: Identifying infected patients and analyzing linkage to care. Clinical liver disease 23 (1) (2024)
Jose C Cessa-Zanatta, Carlos A Cortez-Hernández, Daniela Goyes, Alan Bonder
Epidemiology and health care burden of autoimmune liver diseases in Mexico. Clinical liver disease 23 (1) (2024)
Jennifer Guy
Hepatocellular adenomas (HCAs) and pregnancy. Clinical liver disease 23 (1) (2024)
Alejandro Torres-Hernandez, Patrick G Northup
Not just a clearance: Surgical risk in patients with cirrhosis. Clinical liver disease 23 (1) (2024)
Kyla M Tolliver, Erin J Phipps
Sexual health in adolescents with liver disease: How to counsel kids. Clinical liver disease 23 (1) (2024)
Jose C Cessa-Zanatta, Carlos A Cortez-Hernández, Daniela Goyes, Alan Bonder
Epidemiology and health care burden of autoimmune liver diseases in Mexico. Clinical liver disease 23 (1) (2024)
Anna K Mann, Liz Allan, Kristen P Wheeden, Amy K Dickey, Cynthia Levy
Diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and x-linked protoporphyria: A patient-friendly summary of the 2023 evidence-based consensus guidelines. Clinical liver disease 23 (1) (2024)
Anahita Rabiee, Atoosa Rabiee
Keep beta-blocking and carry on! Clinical liver disease 23 (1) (2024)
Manavi Bhagwat, Nancy S Reau
The delta in management of HDV/HBV coinfection: Lessons from a case. Clinical liver disease 23 (1) (2024)
Georgia Sofia Karachaliou, Ayako Suzuki
Metabolic dysfunction-associated steatotic liver disease: Emerging risk factors for adverse pregnancy outcomes. Clinical liver disease 23 (1) (2024)
Rebecca Roediger, Jaquelyn Fleckenstein
Intrahepatic cholestasis of pregnancy. Clinical liver disease 23 (1) (2024)
Nathalie A Pena Polanco, Cynthia Levy
Autoimmune hepatitis and pregnancy. Clinical liver disease 23 (1) (2024)
Tooba Laeeq, Kyaw Min Tun, Tahne Vongsavath, Aditi Singh, Vignan Manne
Incidence and risk factors of Clostridioides difficile infection in liver transplant recipients: A comprehensive literature review. Clinical liver disease 23 (1) (2024)
Edoardo G Giannini
Proper assessment and prognostication of patients with hepatocellular carcinoma. Clinical liver disease 23 (1) (2024)
Anna K Mann, Liz Allan, Kristen P Wheeden, Amy K Dickey, Cynthia Levy
Diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and x-linked protoporphyria: A patient-friendly summary of the 2023 evidence-based consensus guidelines. Clinical liver disease 23 (1) (2024)
Jennifer Guy
Hepatocellular adenomas (HCAs) and pregnancy. Clinical liver disease 23 (1) (2024)
Manavi Bhagwat, Nancy S Reau
The delta in management of HDV/HBV coinfection: Lessons from a case. Clinical liver disease 23 (1) (2024)
Anahita Rabiee, Atoosa Rabiee
Keep beta-blocking and carry on! Clinical liver disease 23 (1) (2024)
Jing Chen, George Lau
HBV "Viral Elimination" in the Asia-Pacific region: Current status and challenges. Clinical liver disease 23 (1) (2024)
Mary White, Hannah Han, Vandana Khungar
Acute fatty liver disease of pregnancy. Clinical liver disease 23 (1) (2024)
Allison Carroll, Justin Richard Boike
Tips for TIPS recipients: A patient-focused guidance on TIPS. Clinical liver disease 23 (1) (2024)
Kimberley D Lucas, Amy Krawiec, Jonathan Wada, Renee J Kanan
The hepatitis C care cascade in California state prisons: Screening and treatment scale-up and progress toward elimination, 2016-2023. Clinical liver disease 23 (1) (2024)
Rebecca Roediger, Jaquelyn Fleckenstein
Intrahepatic cholestasis of pregnancy. Clinical liver disease 23 (1) (2024)
Isabella C Wiest, Stephen Henry Gilbert, Jakob Nikolas Kather
From research to reality: The role of artificial intelligence applications in HCC care. Clinical liver disease 23 (1) (2024)
Meera Garriga, Grace Zhang, Monika Sarkar
Contraception in patients with liver disease and liver transplant. Clinical liver disease 23 (1) (2024)
Edoardo G Giannini
Proper assessment and prognostication of patients with hepatocellular carcinoma. Clinical liver disease 23 (1) (2024)
Allison Carroll, Justin Richard Boike
Tips for TIPS recipients: A patient-focused guidance on TIPS. Clinical liver disease 23 (1) (2024)
Joseph K Lim
Clinical Liver Disease : Legacy of innovation in hepatology education. Clinical liver disease 23 (1) (2024)
Nathalie A Pena Polanco, Cynthia Levy
Autoimmune hepatitis and pregnancy. Clinical liver disease 23 (1) (2024)
Meera Garriga, Grace Zhang, Monika Sarkar
Contraception in patients with liver disease and liver transplant. Clinical liver disease 23 (1) (2024)
David Weinstein, Dhiren A Shah
Wilson disease and pregnancy. Clinical liver disease 23 (1) (2024)
Mary White, Hannah Han, Vandana Khungar
Acute fatty liver disease of pregnancy. Clinical liver disease 23 (1) (2024)
Gres Karim, Megha Reddy, Navim Mobin, Ilan Weisberg, Amreen M Dinani
Immunosuppression management for refractory checkpoint inhibitor-related hepatotoxicity. Clinical liver disease 23 (1) (2024)
Vicki Shah, Thomas Colletti, Nancy S Reau
Could the answer to NAFLD be hidden in diabetic therapy? The impact of T2DM treatment on NAFLD. Clinical liver disease 23 (1) (2024)
Mette M Lauridsen, Jasmohan S Bajaj
Inpatient management of hepatic encephalopathy. Clinical liver disease 23 (1) (2024)
Chien-Hung Chen
Should we expand treatment initiation for chronic hepatitis B infection? Cons. Clinical liver disease 23 (1) (2024)
Kyla M Tolliver, Erin J Phipps
Sexual health in adolescents with liver disease: How to counsel kids. Clinical liver disease 23 (1) (2024)
Jing Chen, George Lau
HBV "Viral Elimination" in the Asia-Pacific region: Current status and challenges. Clinical liver disease 23 (1) (2024)
Karen Scott, Elizabeth Chappell, Aya Mostafa, Alla Volokha, Nida Najmi, Fatma Ebeid, Svitlana Posokhova, Raheel Sikandar, Marta Vasylyev, Saima Zulfiqar, Viacheslav Kaminskyi, Sarah Pett, Ruslan Malyuta, Ruslana Karpus, Yomna Ayman, Rania H M Ahmed, Saeed Hamid, Manal H El-Sayed, Diana Gibb, Ali Judd, Intira Jeannie Collins
Acceptability of hepatitis C screening and treatment during pregnancy in pregnant women in Egypt, Pakistan, and Ukraine: A cross-sectional survey. Clinical liver disease 23 (1) (2024)
Rahul Grover, Brett E Fortune, Clara Y Tow
The impact of alcohol on patients after bariatric surgery. Clinical liver disease 23 (1) (2024)
Tooba Laeeq, Kyaw Min Tun, Tahne Vongsavath, Aditi Singh, Vignan Manne
Incidence and risk factors of Clostridioides difficile infection in liver transplant recipients: A comprehensive literature review. Clinical liver disease 23 (1) (2024)
Alejandro Torres-Hernandez, Patrick G Northup
Not just a clearance: Surgical risk in patients with cirrhosis. Clinical liver disease 23 (1) (2024)
Mette M Lauridsen, Jasmohan S Bajaj
Inpatient management of hepatic encephalopathy. Clinical liver disease 23 (1) (2024)
David Weinstein, Dhiren A Shah
Wilson disease and pregnancy. Clinical liver disease 23 (1) (2024)